Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06772623 |
| Title | A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Budigalimab in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | AbbVie |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Providence - St. Jude Medical Center /ID# 271414 | RECRUITING | Fullerton | California | 92835 | United States | Details |
| Astera Cancer Care /ID# 271915 | RECRUITING | East Brunswick | New Jersey | 08816-4096 | United States | Details |
| New York Cancer and Blood Specialists - New York /ID# 272547 | RECRUITING | New York | New York | 10028 | United States | Details |
| Millennium Research & Clinical Development /ID# 271717 | RECRUITING | Houston | Texas | 77090 | United States | Details |
| Northwest Medical Specialties Tacoma /ID# 270469 | RECRUITING | Tacoma | Washington | 98405 | United States | Details |
| Pan American Center for Oncology Trials /ID# 268827 | RECRUITING | Rio Piedras | 00935 | Puerto Rico | Details |